(Q51471247)

English

Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Chang-Yu Pan

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

Harald Landen

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

publication date

1 January 2007

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

Clinical Drug Investigation

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

27

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

397-405

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

Global and societal implications of the diabetes epidemic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance--prevalence and conversion to NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Study on the epidemiological characteristics of diabetes mellitus and IGT in China]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug therapy of postprandial hyperglycaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of alpha-glucosidase inhibition in the management of diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200727060-00003

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17506590

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51471247&oldid=1399003506"